Furthermore, A study showed that epidermal growth factor (EGF) can stabilize PD-L1 expression and an EGF inhibitor (gefitinib) might enhance anti-tumor immunity in syngeneic mouse models [38]. The gene discussed is CD274; the disease is neoplasm.